TMDX - Company ID 0001756262
The table below shows TransMedics Group, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $24.53M | -$2.85M | -$3.44M | -$8.66M | -$18.41M | -$7.33M |
| Capital expenditure | $36.66M | $27.04M | $44.17M | $927.00K | $1.95M | $20.00K |
| Investing cash flow | -$36.66M | -$27.04M | -$44.17M | -$927.00K | $10.51M | $9.27M |
| Dividends paid | - | - | - |
TransMedics Group, Inc. reported operating cash flow of $192.84M for fiscal year 2025. That is up 295.1% from $48.80M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$25.98M (FY 2018) to $192.84M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $3.76M | $3.03M | $3.19M | $3.96M | $405.00K | $583.00K |